Reduced urinary glutamate levels are associated with the frequency of migraine attacks in females

European Journal of Neurology

Volumn 19, Issue 8, 2012, Pages 1146-1150

  Ragginer, C ^a   Lechner, A ^a   Bernecker, C ^a   Horejsi, R ^a   Moller R ^a   Wallner Blazek, M ^a   Weiss, S ^a   Fazekas, F ^a   Schmidt, R ^a   Truschnig Wilders, M ^a   Gruber, H J ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Frequency of attacks; Glutamate; Migraine; Urinary

Indexed keywords

C REACTIVE PROTEIN; GLUTAMIC ACID; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINO ACID URINE LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INSULIN METABOLISM; LIPID METABOLISM; LOGISTIC REGRESSION ANALYSIS; METABOLIC DISORDER; MIGRAINE; PRIORITY JOURNAL; RISK;

ADULT; FEMALE; GLUTAMIC ACID; HUMANS; INSULIN; LIPID METABOLISM; MIGRAINE DISORDERS; ODDS RATIO;

EID: 84863864403     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03693.x     Document Type: Article

References (33)

1. Aurora SK, Wilkinson F. The brain is hyperexcitable in migraine. Cephalalgia 2007; 27: 1442-1453.
2. Goadsby PJ, Classey JD. Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow. Brain Res 2000; 875: 119-124.
3. Gonzalez de la Aleja J, Porta-Etessam J, Sepulveda-Sanchez JM, Rodriguez Pena-Marin M. The pathophysiology of migraine. Reflections on the glutamatergic hypothesis. Rev Neurol 2006; 43: 481-488.
4. Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. Arch Neurol 2001; 58: 365-370.
5. Maragakis NJ, Rothstein JD. Glutamate transporters: animal models to neurologic disease. Neurobiol Dis 2004; 15: 461-473.
6. Ramadan NM. The link between glutamate and migraine. CNS Spectr 2003; 8: 446-449.
7. Castillo J, Martinez F, Leira R, Prieto JM, Lema M, Noya M. Changes in neuroexcitatory amino acids during and between migraine attacks. Neurologia 1994; 9: 42-45.
8. Ferrari MD. Biochemistry of migraine. Pathol Biol 1992; 40: 287-292.
9. Martinez F, Castillo J, Rodriguez JR, Leira R, Noya M. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia 1993; 13: 89-93.
10. Peres MF, Zukerman E, Senne Soares CA, Alonso EO, Santos BF, Faulhaber MH. Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 2004; 24: 735-739.
11. Ferrari A, Spaccapelo L, Pinetti D, Tacchi R, Bertolini A. Effective prophylactic treatments of migraine lower plasma glutamate levels. Cephalalgia 2009; 29: 423-429.
12. Marin JC, Goadsby PJ. Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine? Expert Opin Investig Drugs 2010; 19: 555-561.
13. Vieira DS, Naffah-Mazzacoratti Mda G, Zukerman E, Senne Soares CA, Cavalheiro EA, Peres MF. Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. Headache 2007; 47: 842-847.
14. Begni B, Tremolizzo L, D'Orlando C, et al. Substrate-induced modulation of glutamate uptake in human platelets. Br J Pharmacol 2005; 145: 792-799.
15. Taffi R, Vignini A, Lanciotti C, et al. Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods. Cephalalgia 2005; 25: 353-358.
16. Tremolizzo L, DiFrancesco JC, Rodriguez-Menendez V, et al. Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation. Neurosci Lett 2006; 404: 262-265.
17. Vaccaro M, Riva C, Tremolizzo L, et al. Platelet glutamate uptake and release in migraine with and without aura. Cephalalgia 2007; 27: 35-40.
18. Cavestro C, Rosatello A, Micca G, et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache 2007; 47: 1436-1442.
19. Gruber HJ, Bernecker C, Pailer S, et al. Hyperinsulinaemia in migraineurs is associated with nitric oxide stress. Cephalalgia 2010; 30: 593-598.
20. Guldiken B, Guldiken S, Demir M, et al. Insulin resistance and high sensitivity C-reactive protein in migraine. Can J Neurol Sci 2008; 35: 448-451.
21. Headache Classification Subcommittee of the International Headache S. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24(Suppl 1): 9-160.
22. van den Maagdenberg AM, Haan J, Terwindt GM, Ferrari MD. Migraine: gene mutations and functional consequences. Curr Opin Neurol 2007; 20: 299-305.
23. Vikelis M, Mitsikostas DD. The role of glutamate and its receptors in migraine. CNS Neurol Disord Drug Targets 2007; 6: 251-257.
24. Oshinsky ML, Luo J. Neurochemistry of trigeminal activation in an animal model of migraine. Headache 2006; 46(Suppl 1): S39-S44.
25. Zlotnik A, Gruenbaum BF, Mohar B, et al. The effects of estrogen and progesterone on blood glutamate levels: evidence from changes of blood glutamate levels during the menstrual cycle in women. Biol Reprod 2011; 84: 581-586.
26. Bic Z, Blix GG, Hopp HP, Leslie FM. In search of the ideal treatment for migraine headache. Med Hypotheses 1998; 50: 1-7.
27. Rainero I, Limone P, Ferrero M, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia 2005; 25: 593-597.
28. Gruber HJ, Bernecker C, Pailer S, et al. Lipid profile in normal weight migraineurs - evidence for cardiovascular risk. Eur J Neurol 2010; 17: 419-425.
29. Kurth T, Ridker PM, Buring JE. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 2008; 28: 49-56.
30. Monastero R, Pipia C, Cefalu AB, et al. Association between plasma lipid levels and migraine in subjects aged > or =50years: preliminary data from the Zabut Aging Project. Neurol Sci 2008; 29(Suppl 1): S179-S181.
31. Peterlin BL, Rapoport AM, Kurth T. Migraine and obesity: epidemiology, mechanisms, and implications. Headache 2010; 50: 631-648.
32. Peterlin BL, Rosso AL, Rapoport AM, Scher AI. Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache 2010; 50: 52-62.
33. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005; 64: 614-620.